Valeant Pharmaceuticals To Participate In Healthcare Conferences

November 10, 2016

LAVAL, Quebec, Nov. 10, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Joseph C. Papa, Chairman and CEO, will participate in the following healthcare conferences:

  • Stifel 2016 Healthcare Conference on Tuesday, November 15, 2016 at 8:00 a.m. ET at the New York Palace Hotel;
  • Guggenheim 4th Annual Boston Healthcare Conference on Tuesday, December 13, 2016 at 11:45 a.m. ET at the Intercontinental Boston; and,
  • BMO Prescriptions for Success Healthcare Conference on Wednesday, December 14, 2016 at 1:30 p.m. ET at the InterContinental Barclay Hotel in New York City.

A live webcast and audio archive of the events will be available on Valeant's Investor Relations website and via this URL: http://ir.valeant.com/investor-relations/events-and-presentations/default.aspx 

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

Contact Information:
Investors:
Elif McDonald
elif.mcdonald@valeant.com
514-856-3855
877-281-6642 (toll free)

Media:
Renée Soto
or
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.
212-687-8080

Valeant Pharmaceuticals International, Inc.

Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-to-participate-in-healthcare-conferences-300360589.html

SOURCE Valeant Pharmaceuticals International, Inc.